Safety Profile and Side Effects Like other GLP-1 receptor agonists, Mounjaro carries potential risks and side effects that patients and providers must consider: Gastrointestinal symptoms: Nausea, vomiting, diarrhea, and constipation are common, especially during initial dose escalation
In the human body, the PLG polymers slowly degrade through the non-catalyzed hydrolysis of the ester linkages into lactic acid and glycolic acid, which are finally eliminated as carbon dioxide and water
In this video, Noom's Chief Medical Officer, Dr
Liu Z, Liu X, Yang Q, Yu L, Chang Y, Qu M
In contrast, this formula supports the bodys endogenous (natural) production of GLP-1 with patented ingredients, a milder and more sustainable alternative